文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

鼻内镇痛用于急诊科急性疼痛控制:文献综述

The use of intranasal analgesia for acute pain control in the emergency department: A literature review.
PubMed 文献 · Am J Emerg Med · 2017-11-20
一句话结论11项方法学存在缺陷的随机对照试验结论矛盾,支持鼻内镇痛优于传统途径的证据有限;鼻内途径或可作为无法建立静脉通路、患者拒绝注射药物或需快速起效时的替代选择。

该证据评价综述检索了1970年7月至2017年7月的MEDLINE和EMBASE数据库,纳入11项在急诊科评估鼻内镇痛用于急性疼痛的随机对照试验,并用GRADE标准评价方法学质量。结果并不一致:4项试验发现鼻内镇痛组疼痛评分显著降低,但所有试验中疼痛缓解均不持久;3项试验报告对照药物疼痛缓解更优;3项试验报告无统计学显著性;1项试验描述鼻内镇痛有效但未提供统计分析数据。结论认为支持鼻内镇痛优于传统途径的证据有限,鼻内途径或可作为静脉通路不可行、患者拒绝注射药物或需快速起效时的替代选择。

要点

  • 11项急诊科随机对照试验中仅4项发现鼻内镇痛组疼痛评分显著降低,但所有试验中疼痛缓解均不持久。
  • 3项试验报告对照药物疼痛缓解优于鼻内镇痛,3项试验报告组间无统计学显著性,结论相互矛盾。
  • GRADE评价显示纳入的11项随机对照试验存在多种方法学缺陷,支持鼻内镇痛优于传统途径的证据有限。
  • 鼻内途径或可考虑用于静脉通路不可行、患者拒绝注射药物或需要快速起效的镇痛场景。

适用人群与场景

  • 急诊科急性疼痛患者,纳入标准为随机对照试验评估鼻内镇痛用于急诊科急性疼痛。

研究设计与关键结果

  • 研究类型为证据评价综述,检索MEDLINE和EMBASE数据库1970年7月至2017年7月,纳入11项急诊科急性疼痛的随机对照试验,方法学质量用GRADE标准评价。
  • 4项试验发现鼻内镇痛组疼痛评分显著降低,但所有试验中疼痛缓解均不持久。
  • 3项试验报告对照药物疼痛缓解更优,3项试验报告无统计学显著性,1项试验描述鼻内镇痛有效但未提供统计分析数据。

证据类型、等级与局限

  • 证据类型为文献综述,纳入11项随机对照试验,采用GRADE标准评价方法学质量。
  • 结论认为11项随机对照试验存在多种方法学缺陷、结论相互矛盾,支持鼻内镇痛优于传统途径的证据有限。

对床旁实践的改变

  • 作者认为鼻内途径或可作为静脉通路不可行、患者拒绝注射药物或需要快速起效的镇痛场景中的替代选择。
  • 作者认为支持鼻内镇痛优于传统途径的证据有限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traditional routes for administration of pain medications include oral (PO), intravenous (IV), or intramuscular routes (IM). When these routes are not feasible, the intranasal (IN) route may be considered. The objectives of this evidence-based review were: to review the literature which compared the safety and efficacy of IN analgesia to traditional routes and to determine if IN analgesia should be considered over traditional routes for acute pain control in the ED.

METHODS: The MEDLINE and EMBASE databases from July 1970 to July 2017 were searched. Randomized controlled trials (RCT) that evaluated the use of IN analgesia for acute pain in the ED were included. Methodological quality of the trials was assessed using the Grading of Recommendations Assessment, Development, and Evaluation criteria.

RESULTS: Eleven randomized controlled trials (RCT) met the inclusion criteria. Four trials found significant reductions in pain scores, favoring IN analgesia. However, in all of the trials, pain relief was not sustained. Three trials reported superior pain reduction with comparators and three trials reported no statistical significance. One trial described effective pain relief with IN analgesia but did not provide data on statistical analysis.

CONCLUSION: Eleven randomized controlled trials with various methodological flaws revealed conflicting conclusions. There is limited evidence to support the use of the IN analgesia over traditional routes for acute pain in the ED. The IN route may be a good alternative in scenarios where IV access is not feasible, patients are refusing injectable medications, or a fast onset of pain relief is needed.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Sin B, Wiafe J, Ciaramella C, et al. The use of intranasal analgesia for acute pain control in the emergency department: A literature review. Am J Emerg Med. 2017. PMID: 29239753. doi:10.1016/j.ajem.2017.11.043

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。